Unusual Case Report of Malignant Pheochromocytoma Presenting with STEMI

No Thumbnail Available

Date

2023

Journal Title

Journal ISSN

Volume Title

Publisher

Oxford University Press

Open Access Color

OpenAIRE Downloads

OpenAIRE Views

Research Projects

Organizational Units

Journal Issue

Abstract

Background: Pheochromocytomas (PHEOs) are a group of tumours that leads to multiple symptoms and can induce hypercoagulability and promote thrombosis. Pheochromocytomas may also present without elevated serum and urinary markers. We aimed to provide tips and tricks for the diagnostic and therapeutic management of an unusual case of PHEOs. Case summary: Thirty-four-year-old woman with the unremarkable medical history presented with epigastric pain and dyspnoea. Electrocardiogram showed ST-segment elevation in the inferior limb leads. She underwent an emergency coronary angiogram, which showed a high thrombus burden in the distal right coronary artery. A subsequent echocardiogram demonstrated a 31 × 33mm right atrial mass adhering to the inferior vena cava and abdominal computed tomography (CT) scan revealed a 113 × 85mm necrotic mass in the left adrenal bed, with tumour thrombus extending proximally to the confluence of hepatic veins immediately inferior to the right atrium and distally to iliac vein bifurcation. Blood parameters, thrombophilia panel, vanillylmandelic acid, 5 hydroxy indole acetic acid, and homovanillic acid levels were normal. Tissue sampling confirmed the diagnosis of PHEOs. The surgical procedure was not planned due to the presence of metastatic foci on imaging, including positron emission tomography (PET)-CT. Anticoagulation with rivaroxaban and treatment with 177Lu-DOTATATE-based peptide receptor radionuclide therapy (PRRT) was initiated. Discussion: The coexistence of arterial and venous thrombosis is extremely rare in patients with PHEOs. Multidisciplinary approaches are required for the care of such patients. Catecholamines likely contributed to the development of thrombosis in our patient. Early recognition of PHEOs is the key point to ameliorate clinical outcomes. © 2023 Elsevier B.V., All rights reserved.

Description

Keywords

Acute Coronary Syndrome, Case Reports, Pheochromocytoma, Pulmonary Embolisms, 5 Hydroxyindoleacetic Acid, Acetylsalicylic Acid, Clopidogrel, Dopamine, Epinephrine, Homovanillic Acid, Oxodotreotide Lutetium Lu 177, Rivaroxaban, Tirofiban, Vanilmandelic Acid, 5 Hydroxyindoleacetic Acid, Acetylsalicylic Acid, Clopidogrel, Dopamine, Epinephrine, Homovanillic Acid, Oxodotreotide Lutetium Lu 177, Rivaroxaban, Tirofiban, Vanilmandelic Acid, Abdominal Tenderness, Adult, Anticoagulant Therapy, Article, Ascites, Body Mass, Cancer Diagnosis, Case Report, Clinical Article, Computer Assisted Tomography, Coronary Angiography, Coronary Artery Dissection, Coronary Care Unit, Cytoplasm, Diaphoresis, Disease Burden, Dyspnea, Electrocardiogram, Emergency Ward, Epigastric Pain, Female, Heart Auscultation, Heart Rate, Heart Tumor, Hematological Parameters, Human, Hypotension, Immunity, Inferior Cava Vein, Medical History, Nausea and Vomiting, Peptide Receptor Radionuclide Therapy, Pheochromocytoma, Physical Examination, Positron Emission Tomography-Computed Tomography, Pseudoinclusion, Resuscitation, Right Coronary Artery, Septic Shock, ST Segment Elevation, St Segment Elevation Myocardial Infarction, Thrombophilia, Tumor Thrombus, Vancomycin-Resistant Enterococcus Infection

Turkish CoHE Thesis Center URL

Fields of Science

Citation

WoS Q

N/A

Scopus Q

Q3

Source

European Heart Journal-Case Reports

Volume

7

Issue

7

Start Page

End Page

Sustainable Development Goals

SDG data could not be loaded because of an error. Please refresh the page or try again later.